We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
355 hedge funds and large institutions have $4.02B invested in ADMA Biologics in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 140 increasing their positions, 119 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
84% more call options, than puts
Call options by funds: $68.1M | Put options by funds: $37M
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
23% more capital invested
Capital invested by funds: $3.28B → $4.02B (+$741M)
18% more repeat investments, than reductions
Existing positions increased: 140 | Existing positions reduced: 119
0.71% more ownership
Funds ownership: 91.91% → 92.62% (+0.71%)
3% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 61
3% less funds holding
Funds holding: 365 → 355 (-10)
Holders
355
Holders Change
-10
Holders Change %
-2.74%
% of All Funds
4.32%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
59
Increased
140
Reduced
119
Closed
61
Calls
$68.1M
Puts
$37M
Net Calls
+$31.1M
Net Calls Change
-$5.13M
Top Buyers
Top Sellers
| 1 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$39.8M |
| 2 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
-$31.1M |
| 3 |
Goldman Sachs
New York
|
-$31M |
| 4 |
Renaissance Technologies
New York
|
-$20.9M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20.8M |
